Boosting Humoral Immunity from mRNA COVID-19 Vaccines in Kidney Transplant Recipients

Introduction: The immune response to the primary (two-dose) series of mRNA COVID-19 vaccines in kidney transplant recipients (KTRs) is very weak. We conducted a longitudinal observational study to compare the humoral response to a third, additional primary dose of mRNA vaccines between infection-naï...

Descripción completa

Detalles Bibliográficos
Autores principales: Tylicki, Leszek, Dębska-Ślizień, Alicja, Muchlado, Marta, Ślizień, Zuzanna, Gołębiewska, Justyna, Dąbrowska, Małgorzata, Biedunkiewicz, Bogdan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8779302/
https://www.ncbi.nlm.nih.gov/pubmed/35062717
http://dx.doi.org/10.3390/vaccines10010056

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8779302/
https://www.ncbi.nlm.nih.gov/pubmed/35062717
http://dx.doi.org/10.3390/vaccines10010056

Ejemplares similares